ARTICLE | Clinical News
Equasym XL methylphenidate extended-release capsules regulatory update
May 29, 2006 7:00 AM UTC
UCB completed the European Mutual Recognition Procedure (MRP) for Equasym XL to treat symptoms of attention deficit hyperactivity disorder (ADHD). The U.K. acted as the reference member state. The com...